Business Context and Reporting Period
Company: Leggett & Platt, Incorporated (LEG)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: An international diversified manufacturer of engineered components for bedding, automotive, aerospace, furniture, flooring, and textile industries. Operations are organized into three segments: Bedding Products, Specialized Products, and Furniture, Flooring & Textile Products.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Net Trade Sales | $4,384 million | $4,725 million | (7%) |
| EBIT (Earnings Before Interest and Taxes) | $(430) million | $(90) million | Worsened |
| Net Earnings (Loss) | $(511) million | $(137) million | Worsened |
| Diluted EPS | $(3.73) | $(1.00) | Worsened |
| Cash from Operations | $306 million | $497 million | (38%) |
| Total Debt | $1,864 million | $1,988 million | (6%) |
| Cash and Cash Equivalents | $350 million | $366 million | (4%) |
| Dividends Per Share | $0.61 | $1.82 | (66%) |
Margins: The filing does not explicitly state a consolidated gross margin percentage, but EBIT margin declined from -1.9% in 2023 to -9.8% in 2024.
Material Changes vs. Prior Period
- Revenue Decline: Organic sales decreased 7% due to a 4% volume decline and 3% raw material-related price decreases. The Bedding Products segment saw the largest sales drop (-11%).
- Significant Impairments: The company recorded $676 million in non-cash goodwill impairments (Bedding, Work Furniture, and Hydraulic Cylinders reporting units) and $6 million in long-lived asset impairments. This contrasts with 2023, which had a $444 million long-lived asset impairment but no goodwill impairment.
- Restructuring: The "2024 Restructuring Plan" was initiated, involving facility consolidations and workforce reductions. Total restructuring and related costs for 2024 were $51 million ($33 million cash).
- Dividend Reduction: The annual dividend was reduced by 66% to $0.61 per share to preserve cash for deleveraging.
- Debt Management: Total debt decreased by $124 million. The company repaid $300 million of senior notes using commercial paper.
Guidance, Outlook, and Risks
Outlook and Guidance
- 2025 Demand: Management expects overall demand in 2025 to be down modestly from 2024 levels due to macroeconomic pressures.
- Restructuring Benefits: The 2024 Plan is expected to be substantially complete by the end of 2025, with estimated total annualized EBIT benefits of $60–$70 million and sales attrition of $80 million.
- Capital Expenditures: Expected to approximate $100 million in 2025.
- Portfolio Review: The company is exploring the potential sale of its Aerospace business, which has not yet been classified as held for sale.
Key Risks and Contingencies
- Goodwill Impairment Risk: Significant portions of assets are goodwill and long-lived assets. Further impairments could occur if actual results differ from assumptions.
- Supply Chain: Risks include raw material shortages (steel, chemicals, semiconductors), geopolitical conflicts (China/Taiwan, Red Sea), and trade tariffs.
- Customer Concentration: The largest customer represented less than 8% of sales; top 10 customers accounted for 32%. Loss of key customers could be material.
- Liquidity and Covenants: Credit ratings have been lowered. The company amended its credit facility leverage ratio covenant to 4.00:1.00 through mid-2025. Failure to comply could restrict borrowing capacity.
- Climate Change: Physical risks (wildfires, droughts) and transition risks (regulatory compliance) could impact operations and costs.
Investor Verification Checklist
- Impairment Assumptions: Verify the fair value calculations and discount rates used for the $676 million goodwill impairment, particularly for the Bedding reporting unit.
- Restructuring Execution: Monitor the timeline and cost realization of the 2024 Restructuring Plan against the estimated $80–$90 million total cost and $60–$70 million EBIT benefit.
- Debt Covenant Compliance: Track the Leverage Ratio (Funded Indebtedness minus Unrestricted Cash to EBITDA) to ensure compliance with the 4.00:1.00 threshold through June 2025.
- Bedding Segment Health: Assess the financial stability of key bedding customers and the impact of import competition on domestic innerspring sales.
- Aerospace Divestiture: Watch for updates on the potential sale of the Aerospace business and any associated transaction costs or gains.
- Working Capital: Review Days Sales Outstanding (DSO) and inventory levels, as customer financial stress has led to increased bad debt reserves.